Study of IMC-1121B in Patients With Tumors That Have Not Responded to Therapy

Clinical trial NCT00793975 · COMPLETED

Trial details

NCT number: NCT00793975
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2005-01-01
Primary completion: 2009-06-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.